Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

VYNE

VYNE Therapeutics Inc.

CIK 0001566044 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.67
↑ 0.02 (3.35%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$22.41M
P/E Ratio
-1.04
EPS
-0.62
Dividend Yield
Not covered
52W Position
30%
Beta
0.55

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.91
P/S
49.37
EV/Revenue
-4.89
ROE
-87.1%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 30%
$0.28$1.59

Latest Financials

2025-12-31 FY
Revenue
$570.00K
Net Income
-$26.48M
Total Assets
$30.16M
Free Cash Flow
–

Recent news